Israel Chemical (ICL) Tops Q2 EPS by 4c

Israel Chemical (NYSE: ICL) reported Q2 EPS of $0.10, $0.04 better than the analyst estimate of $0.06. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.26 billion.

For earnings history and earnings-related data on Israel Chemical (ICL) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Minerva Neurosciences (NERV) Tops Q2 EPS by 5c
• Evommune, Inc. (EVMN) Misses Q2 EPS by 20c